Principal Financial Group Inc Innoviva, Inc. Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$16.33 - $20.04 $327,547 - $401,962	-20,058 Reduced 6.54%	286,777 $5.53 Million
Q2 2024 Jul 29, 2024	SELL	$14.4 - $16.4 $247,046 - $281,358	-17,156 Reduced 5.3%	306,835 $5.03 Million
Q1 2024 Apr 29, 2024	BUY	$14.56 - $16.78 $16,321 - $18,810	1,121 Added 0.35%	323,991 $4.94 Million
Q4 2023 Feb 07, 2024	SELL	$12.32 - $16.27 $93,718 - $123,765	-7,607 Reduced 2.3%	322,870 $5.18 Million
Q3 2023 Nov 02, 2023	SELL	$12.37 - $13.89 $235,933 - $264,923	-19,073 Reduced 5.46%	330,477 $4.29 Million
Q2 2023 Aug 07, 2023	SELL	$11.39 - $13.72 $483,471 - $582,372	-42,447 Reduced 10.83%	349,550 $4.45 Million
Q1 2023 May 09, 2023	SELL	$10.73 - $13.6 $116,195 - $147,274	-10,829 Reduced 2.69%	391,997 $4.41 Million
Q4 2022 Feb 09, 2023	SELL	$11.8 - $13.78 $176,811 - $206,479	-14,984 Reduced 3.59%	402,826 $5.34 Million
Q3 2022 Nov 09, 2022	SELL	$11.61 - $15.22 $617,257 - $809,186	-53,166 Reduced 11.29%	417,810 $4.85 Million
Q2 2022 Aug 10, 2022	SELL	$14.32 - $19.88 $372,420 - $517,019	-26,007 Reduced 5.23%	470,976 $6.95 Million
Q1 2022 May 09, 2022	SELL	$15.39 - $20.25 $567,290 - $746,435	-36,861 Reduced 6.9%	496,983 $9.62 Million
Q4 2021 Feb 09, 2022	SELL	$15.91 - $18.72 $202,677 - $238,474	-12,739 Reduced 2.33%	533,844 $9.21 Million
Q3 2021 Nov 09, 2021	SELL	$13.06 - $17.24 $124,122 - $163,848	-9,504 Reduced 1.71%	546,583 $9.13 Million
Q2 2021 Aug 10, 2021	SELL	$11.45 - $13.96 $175,711 - $214,230	-15,346 Reduced 2.69%	556,087 $7.46 Million
Q1 2021 May 10, 2021	BUY	$11.06 - $12.87 $70,651 - $82,213	6,388 Added 1.13%	571,433 $6.83 Million
Q4 2020 Feb 08, 2021	BUY	$9.33 - $12.48 $274,246 - $366,837	29,394 Added 5.49%	565,045 $7 Million
Q3 2020 Nov 06, 2020	SELL	$10.33 - $14.49 $204,678 - $287,104	-19,814 Reduced 3.57%	535,651 $5.6 Million
Q2 2020 Aug 05, 2020	BUY	$11.49 - $15.26 $98,974 - $131,449	8,614 Added 1.58%	555,465 $7.77 Million
Q1 2020 May 12, 2020	SELL	$8.11 - $15.23 $168,752 - $316,905	-20,808 Reduced 3.67%	546,851 $6.43 Million
Q4 2019 Feb 05, 2020	SELL	$10.28 - $14.38 $366,913 - $513,250	-35,692 Reduced 5.92%	567,659 $8.04 Million
Q3 2019 Nov 13, 2019	SELL	$10.05 - $14.55 $124,449 - $180,172	-12,383 Reduced 2.01%	603,351 $6.36 Million
Q2 2019 Aug 12, 2019	BUY	$13.1 - $14.95 $153,283 - $174,929	11,701 Added 1.94%	615,734 $8.97 Million
Q1 2019 May 10, 2019	SELL	$13.69 - $20.06 $52,802 - $77,371	-3,857 Reduced 0.63%	604,033 $8.47 Million
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $87,473 - $114,417	6,266 Added 1.04%	607,890 $10.6 Million
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $356,165 - $410,256	26,131 Added 4.54%	601,624 $9.17 Million
Q2 2018 Aug 13, 2018	SELL	$13.44 - $17.59 $373,968 - $489,441	-27,825 Reduced 4.61%	575,493 $0
Q1 2018 May 14, 2018	SELL	$13.8 - $16.99 $133,101 - $163,868	-9,645 Reduced 1.57%	603,318 $10.1 Million
Q4 2017 Feb 13, 2018	SELL	$11.73 - $14.75 $88,467 - $111,244	-7,542 Reduced 1.22%	612,963 $8.7 Million
Q3 2017 Nov 02, 2017	BUY	$12.06 - $14.12 $7.48 Million - $8.76 Million	620,505	620,505 $8.76 Million

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

Black Rock Inc. New York, NY

9.63M
Shares

$171 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

7.28M
Shares

$129 Million
34.93% of portfolio
Franklin Resources Inc San Mateo, CA

6.75M
Shares

$120 Million
0.04% of portfolio
Putnam Investments LLC Boston, MA

6.27M
Shares

$112 Million
0.14% of portfolio
Vanguard Group Inc Valley Forge, PA

6.23M
Shares

$111 Million
0.0% of portfolio

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account